Baxter recalls buretrol solution sets over potential embolism risk
Baxter issues an urgent product recall for a set of buretrol fluid delivery systems manufactured and distributed since 2003 over potential air bubbles created by the device that could make their way into a patient's bloodstream.
Baxter (NYSE:BAX) issued an urgent product recall covering 9 years' worth of its Clearlink and Interlink buretrol solution sets over concerns that the devices "may cause serious adverse health consequences, including death."
The buretrol systems are disposable IV pathways and are used to administer fluids to a patient's bloodstream by connecting to a vascular access device. The product line is a small one for Baxter, and the company has alternative buretrol solutions sets available for customers, company spokesman Bill Rader told MassDevice.com today.